Overview Scientific Staff


Bart Metselaar - Liposoma

Pharmacist | Director R&D and Manufacturing

Involvement with LIPOSOMA

Since March 2018 Bart has worked for LIPOSOMA as a scientific advisor. In January 2019 Bart started as Pharmacist | Director R&D and Manufacturing.

  • Doctoral in Pharmaceutical Sciences (1995) at University of Utrecht.
  • PharmD degree (1998) at University of Utrecht including an internship in pharmacology at University of Florida at the Department of Pharmaceutics.
  • PhD at the Department of Pharmaceutics and Immunology (1999) at University of Utrecht, with a focus on liposomal formulations for inflammation.
Professional career

After his PhD and postdoctoral tenure at Utrecht University he founded Enceladus Pharmaceuticals BV in 2005. Here he has clinically developed his most important inventions in the field of liposomes into a portfolio of new advanced drugs for arthritis, bowel, and eye diseases.

Bart succeeded in conducting a series of preclinical and clinical studies on two different liposomal nanomedicine products. He was able to finance these studies by securing a series of research grants, two major company awards, various investments and pharmaceutical partnerships.

Since 2012 Bart has been working as a part-time associate professor of advanced drug delivery at University of Twente. In 2015 he took a part-time group leader position at the Rheinisch-Westfälische Technische Hochschule (RWTH) in Aachen. There he expanded his research into the development of liposomal nanomedicines for the treatment of hematological cancers and solid tumors.

Scientific ranking
  • On the international assessment body Expertscape Bart Metselaar has a top ranking on the list for liposomes.
  • H-index 29 (Google Scholar, September 1st, 2019)

Gregorz - Liposoma

Biochemist | senior product engineer Liposoma Health BV

Involvement with LIPOSOMA

In 2018 Greg Pawlik joined LIPOSOMA. At Liposoma he’s responsible for feasibility studies, the development of new liposome formulations and stabilization methods.

  • Master of Science in Biotechnology (2008) at University of Silesia in Katowice, Poland.
  • PhD at Albert Ludwigs Universität in Freiburg, Germany, with a focus on the bioenergetics of biological membranes and the biogenesis of membrane proteins.
Professional career

When Greg Pawlik successfully completed his thesis he moved to Paris. During a traineeship at the Centre National de la Recherche Scientifique (CNRS), he studied membrane targeting drugs.

In 2013 he took a postdoctoral position at the Membrane Biochemistry and Biophysics group at University of Utrecht. He studied the processes of biosynthesis of phospholipids in yeast. Two years later he joined the Department of Bionanoscience at Technical University Delft. He was involved in a synthetic cell project, investigating the use of bacterial protein systems for the division of liposomes: minimal cell models. Greg was also part of a project focused on the development of point-of-care diagnostics for rapid detection of pathogens.

Martino - Liposoma

Chemist | senior product engineer Liposoma Health BV

Involvement with LIPOSOMA

Martino Ambrosini joined LIPOSOMA in 2019, keen to add his expertise to the group. At Liposoma he’s responsible for quality control, feasibility studies, development of new liposome formulations and stabilization methods.

  • Master of Science in Chemistry (2004) at University of Ferrara in Italy, including an internship at GlaxoSmithKline pharmaceutical company.
  • PhD (2009) in Chemical Sciences focusing on reactivity studies and full synthesis of organic compounds active on the central nervous system.
Professional career

Between 2005 and 2009, he trained for two years in GlaxoSmithKline pharmaceutical company in the medicinal chemistry department. Together with an increased knowledge in organic synthesis and state-of-the-art instrumentation, he acquired a good overview of a big company’s objectives and regulations. He then moved in 2009 to the Netherlands to join DC4U, eager to expand his expertise in immunology and the related chemistry and biochemistry. Working in close collaboration with the Molecular Cell Biology and Immunology department at the Free University Medical Centre, he was involved in many projects aiming to vaccinate against cancer and autoimmune diseases. He was responsible for the design and synthesis of glycan-antigen conjugates, lead product optimization and quality control. He also developed receptor-targeting liposomal formulations in collaboration with the group of Gert Storm at UIPS in Utrecht.

Gert Storm - Liposoma

Professor targeted drug delivery | scientific advisor LIPOSOMA

Involvement with LIPOSOMA

Since 2017 Gert Storm has been involved with LIPOSOMA as a scientific advisor. Because he is globally recognized as a top expert in the field of liposome preparation and application, he serves as a bridge between LIPOSOMA and academic resources. His scientific ranking (see below) and academic network underline his importance for our company.

  • Doctoral in Biology (1983) at University of Utrecht in the Netherlands.
  • PhD at the Department of Pharmaceutics (1987) at University of Utrecht including a thesis entitled “Liposomes as delivery system for doxorubicin in cancer chemotherapy”.
Professional career

After his PhD, Gert worked as a scientist at Liposome Technology Inc. in Menlo Park, USA, and as a guest professor at the School of Pharmacy, part of the University of California in San Francisco. In 1990-1991 he was senior scientist at Pharma Bio-Research Consultancy B.V. in the Netherlands, working on the design, coordination and evaluation of clinical pharmacological studies.
In 1991 he returned to the Department of Pharmaceutics at the Utrecht University. Currently, he is also part-time professor Targeted Therapeutics at the Department of Biomaterials Science & Technology of the University of Twente and Honorary Professor Biomacromolecular Drug Delivery at the University of Copenhagen. He also held a position (seconded) at the University Medical Center Utrecht (UMCU), Division Imaging.
Gert Storm’s research interest is mainly concerned with the design, characterization and (pre) clinical testing of targeted nanomedicine formulations, in particular liposome-based formulations.

Scientific ranking
  • More than 550 publications.
  • H-index 95 (Google Scholar, August 1st 2019).
  • Since the start in 2014, he is every year included in the lists of The World’s Most Influential Scientific Minds by Thomson Reuters (in 2018 taken over by Clarivate Analytics), as Highly Cited Researcher.
  • Based on scientific publications since 2009, Expertscape objectively ranks scientists per scientific field  1) for ‘liposomes’ 2nd worldwide/1st in Europe, 2) for ‘drug carriers’ 2nd worldwide/1st in Europe, and 3) for ‘drug delivery systems’ 3rd worldwide/ 2nd in Europe (date: July 26, 2019).

Gert Storm - Liposoma

Cell biologist | independent biotechnology professional | scientific advisor at LIPOSOMA

Involvement with LIPOSOMA

Nico van Rooijen contributed the results of his research to LIPOSOMA. “I really like to see how my theoretical research has now gained a practical meaning at LIPOSOMA.” As a scientific advisor he still adds value to our company.

  • Doctoral in Biology (1967) at Vrije Universiteit Amsterdam.
  • PhD in cell biology (1974) at Vrije Universiteit Amsterdam.
Professional career

As a cell biologist, Nico van Rooijen has devoted his entire scientific career to research on the immune system. He was the first to apply clodronate liposomes. He collected a wealth of knowledge about the functionality of these liposomes. Read the full story of Nico van Rooijen’s scientific search and how that is related to LIPOSOMA.

Scientific ranking
  • On the Expertscape Nico van Rooijen has top ranking on the list for liposomes.
  • More than 900 publications.
  • H-index 148 (Google Scholar, September 1st, 2019)

Contact us

Allow us to send you occasional updates


LIPOSOMA is situated at the Amsterdam Science Park, a vibrant melting pot where science, business and innovation meet. The park hosts the University of Amsterdam’s Faculty of Science, the Amsterdam University College, dozens of renowned research institutes and some 150 companies, from star t-ups to multinationals.

We are proud that LIPOSOMA is one of these companies, literally located at the interface of science and entrepreneurship.

Science Park 408
The Netherlands
VAT: NL8524.12.551.B01
Commercial Chamber: 57037108
Phone: +31 (0)20 237 3600